UroGen Pharma
Price & Volume
Stats
See moreOpen | $9.85 |
Previous Close | $9.66 |
Day Range | $9.85-$10.26 |
52W Range | $8.94-$20.70 |
Market Cap | $445.7M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $90.3M |
Revenue Growth (YoY) | 4.4% |
Gross Profit (12 Mos) | $81.5M |
Diluted EPS | -$2.96 |
News
See moreYahoo Finance • 2 years ago
Retrospective Study Finds JELMYTO® Use Effective Following Partial Ablation or Biopsy in Larger Volume Low-Grade Upper Tract Urothelial Tumors that Impede Kidney Preservation
Yahoo Finance • 2 years ago
Retrospective Study Reveals Lower Stricture Rate and Comparable Oncological Outcomes with Antegrade Administration of JELMYTO® Versus Retrograde Administration
Yahoo Finance • 2 years ago
UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2023 Earnings Call Transcript
Yahoo Finance • 2 years ago
UroGen Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Ms. Elizabeth A. Barrett |
Address | 400 Alexander Park Drive, Princeton, NJ, United States, 08540 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 235 |
